KG
Kelsey Goodwin Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Summit Therapeutics
SMMT
$19.3B
| $25.98 | $21 |
19%
downside
| Neutral | 17 days ago |
|
2
Janux Therapeutics
JANX
$1.44B
| $23.98 | $42 |
75%
upside
| Overweight | 18 days ago |
|
3
Revolution Medicines
RVMD
$7.57B
| $40.50 | $75 |
85%
upside
| Overweight | 18 days ago |
|
4
UroGen Pharma
URGN
$873M
| $18.88 | $36 |
91%
upside
| Overweight | 18 days ago |
|
5
CG Oncology
CGON
$2.52B
| $33.07 | $55 |
66%
upside
| Overweight | 18 days ago |
|
6
Tango Therapeutics
TNGX
$772M
| $6.94 | $11 |
59%
upside
| Overweight | 18 days ago |
|
7
Nuvalent
NUVL
$5.83B
| $80.89 | $112 |
38%
upside
| Overweight | 18 days ago |
|
|
BCAX
8
Bicara Therapeutics Inc. Common Stock
BCAX
$658M
| $12.06 | $36 |
199%
upside
| Overweight | 18 days ago |
|
|
9
UroGen Pharma
URGN
$873M
| $18.88 | $30 |
59%
upside
| Buy | 2 months ago |
|
|
10
Nuvalent
NUVL
$5.83B
| $80.89 | $105 |
30%
upside
| Buy | 11 months ago |
|